Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma
To explore the possibility that the excitatory amino acid glutamate might be associated with the disease process of glaucoma, which is characterized by the death of retinal ganglion cell neurons and subsequent visual dysfunction. Amino acid analyses were performed on vitreous specimens that were obt...
Saved in:
Published in | Archives of ophthalmology (1960) Vol. 114; no. 3; p. 299 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.03.1996
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | To explore the possibility that the excitatory amino acid glutamate might be associated with the disease process of glaucoma, which is characterized by the death of retinal ganglion cell neurons and subsequent visual dysfunction.
Amino acid analyses were performed on vitreous specimens that were obtained from patients who were undergoing cataract extraction. Samples were collected prospectively from those patients who sustained inadvertent rupture of the posterior capsule between 1988 and 1993. An additional set of specimens, obtained from both eyes of monkeys, was analyzed; in these monkeys, glaucoma had been experimentally induced in one eye only.
A twofold elevation in the level of glutamate was detected in the vitreous body of the group of patients with glaucoma when compared with that in a control population of patients with cataracts only. An even greater elevation of the glutamate level was found in the vitreous body of glaucomatous eyes of monkeys when compared with that in control eyes. No statistical differences were detected among other amino acid levels from the vitreous body of glaucomatous and nonglaucomatous eyes in humans or monkeys.
The excitatory amino acid glutamate is found in the vitreous body of glaucomatous eyes at concentrations that are potentially toxic to retinal ganglion cells. The increased level of this known neurotoxin is consistent with an "excitotoxic" mechanism for the retinal ganglion cell and optic nerve damage in glaucoma. Therapies to protect neurons against glutamate toxic effects may prove to be useful in the management of this blinding disease. |
---|---|
AbstractList | To explore the possibility that the excitatory amino acid glutamate might be associated with the disease process of glaucoma, which is characterized by the death of retinal ganglion cell neurons and subsequent visual dysfunction.
Amino acid analyses were performed on vitreous specimens that were obtained from patients who were undergoing cataract extraction. Samples were collected prospectively from those patients who sustained inadvertent rupture of the posterior capsule between 1988 and 1993. An additional set of specimens, obtained from both eyes of monkeys, was analyzed; in these monkeys, glaucoma had been experimentally induced in one eye only.
A twofold elevation in the level of glutamate was detected in the vitreous body of the group of patients with glaucoma when compared with that in a control population of patients with cataracts only. An even greater elevation of the glutamate level was found in the vitreous body of glaucomatous eyes of monkeys when compared with that in control eyes. No statistical differences were detected among other amino acid levels from the vitreous body of glaucomatous and nonglaucomatous eyes in humans or monkeys.
The excitatory amino acid glutamate is found in the vitreous body of glaucomatous eyes at concentrations that are potentially toxic to retinal ganglion cells. The increased level of this known neurotoxin is consistent with an "excitotoxic" mechanism for the retinal ganglion cell and optic nerve damage in glaucoma. Therapies to protect neurons against glutamate toxic effects may prove to be useful in the management of this blinding disease. |
Author | Zurakowski, D Lipton, S A Schumer, R A Podos, S M Dreyer, E B |
Author_xml | – sequence: 1 givenname: E B surname: Dreyer fullname: Dreyer, E B organization: Glaucoma Consultation Service, Massachusetts Eye and Ear Infirmary, Boston, 02114, USA – sequence: 2 givenname: D surname: Zurakowski fullname: Zurakowski, D – sequence: 3 givenname: R A surname: Schumer fullname: Schumer, R A – sequence: 4 givenname: S M surname: Podos fullname: Podos, S M – sequence: 5 givenname: S A surname: Lipton fullname: Lipton, S A |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/8600890$$D View this record in MEDLINE/PubMed |
BookMark | eNotjzFPwzAUhD0UlbbwE5A8sCY8J7YTj6gqFKkSEoK5suNnEkjiKnaK8u8JotPdfcPpbk0Wve-RkHsGKQNgD3qoan-qY8qUkimwP5hDpgSwbEFWAJAnak7XZB3C1xwlA7Uky1IClApW5G3X4llHtPSzHaPuZktngm2gTU9jjfTcxAH9GKjxdqLe0XrsdB-o7i3tfP-NU6A_TaznAj1WvtM35MrpNuDtRTfk42n3vt0nh9fnl-3jIdG5FDGZZxaYMWFywUoOwnAnWeF4icjAVM5krtJccnQFWskLraCUvILclMJJa7INufvvPY2mQ3s8DU2nh-l4-Zb9Ao3PVUI |
CitedBy_id | crossref_primary_10_1016_j_jfo_2009_03_017 crossref_primary_10_1016_j_jneumeth_2006_06_013 crossref_primary_10_1016_j_neuropharm_2013_04_018 crossref_primary_10_1089_hum_2019_056 crossref_primary_10_1007_s00210_012_0796_1 crossref_primary_10_3892_etm_2011_239 crossref_primary_10_1016_S0006_8993_97_01189_X crossref_primary_10_1007_s00347_004_1131_0 crossref_primary_10_1038_npjamd_2016_3 crossref_primary_10_1016_j_biopha_2022_112911 crossref_primary_10_1006_exer_2001_1072 crossref_primary_10_1124_pr_110_004036 crossref_primary_10_1016_j_brainresbull_2006_07_009 crossref_primary_10_1080_02713680490517917 crossref_primary_10_1080_02713680701758719 crossref_primary_10_1080_02713680701226808 crossref_primary_10_1046_j_1471_4159_2002_00819_x crossref_primary_10_1177_026119291604400608 crossref_primary_10_2460_ajvr_2004_65_776 crossref_primary_10_1016_j_neulet_2010_08_061 crossref_primary_10_3171_FOC_2008_24_3_4_E10 crossref_primary_10_1016_j_arr_2016_05_012 crossref_primary_10_1016_j_biopha_2020_109998 crossref_primary_10_1186_s12886_015_0044_9 crossref_primary_10_1016_S1350_9462_02_00012_5 crossref_primary_10_1186_1471_2202_11_31 crossref_primary_10_1016_j_preteyeres_2020_100875 crossref_primary_10_1002_glia_20030 crossref_primary_10_1007_s00347_004_1104_3 crossref_primary_10_1038_eye_2012_84 crossref_primary_10_1089_acm_2005_11_315 crossref_primary_10_1016_j_neulet_2017_10_055 crossref_primary_10_1007_s10633_017_9575_0 crossref_primary_10_1097_00055735_200004000_00002 crossref_primary_10_1007_s12031_017_0978_x crossref_primary_10_1016_S0042_6989_96_00167_8 crossref_primary_10_1016_S0306_3623_97_00362_5 crossref_primary_10_1097_00055735_200004000_00007 crossref_primary_10_1089_108076803321908338 crossref_primary_10_1042_NS20210038 crossref_primary_10_1371_journal_pone_0049730 crossref_primary_10_3390_ijms23042133 crossref_primary_10_1016_S0039_6257_01_00200_4 crossref_primary_10_1016_j_jprot_2016_06_034 crossref_primary_10_1016_S0165_5728_02_00367_3 crossref_primary_10_1016_S1350_9462_98_00008_1 crossref_primary_10_1016_j_preteyeres_2012_02_001 crossref_primary_10_1186_1742_2094_9_92 crossref_primary_10_1089_08977150151071017 crossref_primary_10_1016_j_cvsm_2015_06_002 crossref_primary_10_1016_S0039_6257_01_00208_9 crossref_primary_10_2460_ajvr_2002_63_257 crossref_primary_10_1016_S1350_9462_01_00022_2 crossref_primary_10_1016_S0006_8993_98_00212_1 crossref_primary_10_1016_j_exer_2015_04_013 crossref_primary_10_1371_journal_pone_0223208 crossref_primary_10_1097_01_ijg_0000243480_67532_1b crossref_primary_10_1017_S0952523806230189 crossref_primary_10_1016_S1357_4310_99_01592_0 crossref_primary_10_1186_s12920_021_00960_9 crossref_primary_10_56951_medicinus_v36i2_119 crossref_primary_10_1007_s00347_004_1130_1 crossref_primary_10_3109_02713683_2011_645105 crossref_primary_10_1016_j_preteyeres_2011_11_002 crossref_primary_10_3389_fnagi_2016_00073 crossref_primary_10_1016_j_preteyeres_2024_101261 crossref_primary_10_1016_S0002_9440_10_63558_4 crossref_primary_10_1016_j_exer_2018_03_019 crossref_primary_10_1016_j_neulet_2004_03_082 crossref_primary_10_1016_S0039_6257_99_00026_0 crossref_primary_10_23736_S2785_1265_23_01882_7 crossref_primary_10_3390_ijms19041218 crossref_primary_10_1016_j_jcjd_2013_05_004 crossref_primary_10_1016_j_parkreldis_2007_07_018 crossref_primary_10_1054_mehy_1999_0025 crossref_primary_10_1016_j_ejphar_2016_04_030 crossref_primary_10_3109_02713680903514675 crossref_primary_10_1016_j_ejphar_2016_04_031 crossref_primary_10_3109_13816819609057889 crossref_primary_10_1007_s00441_020_03240_7 crossref_primary_10_1016_j_exer_2021_108826 crossref_primary_10_1186_1471_2156_2_1 crossref_primary_10_1016_j_jfo_2014_11_004 crossref_primary_10_1517_14728214_7_1_141 crossref_primary_10_1016_j_redox_2015_04_004 crossref_primary_10_1517_14728214_4_1_333 crossref_primary_10_1016_S0169_328X_00_00224_2 crossref_primary_10_1038_eye_2016_300 crossref_primary_10_1016_S0039_6257_97_80033_1 crossref_primary_10_1084_jem_20101202 crossref_primary_10_1097_00004397_200101000_00011 crossref_primary_10_1006_exer_1999_0809 crossref_primary_10_1038_sj_bjp_0706949 crossref_primary_10_1254_jjp_89_44 crossref_primary_10_1364_BOE_494271 crossref_primary_10_1111_j_1471_4159_2008_05606_x crossref_primary_10_1007_s00347_004_1116_z crossref_primary_10_1177_107385849700300607 crossref_primary_10_1016_j_exer_2014_11_012 crossref_primary_10_1097_00061198_200302000_00014 crossref_primary_10_1002_glia_20000 crossref_primary_10_1002_jnr_10129 crossref_primary_10_1007_s00216_008_2304_5 crossref_primary_10_1016_S0953_4431_97_10006_6 crossref_primary_10_1177_11206721231161101 crossref_primary_10_1016_j_exer_2008_02_004 crossref_primary_10_1371_journal_pone_0069250 crossref_primary_10_1097_00061198_200210000_00005 crossref_primary_10_1007_s00216_006_0836_0 crossref_primary_10_1016_j_neuropharm_2020_108016 crossref_primary_10_1111_j_1463_5224_2007_00564_x crossref_primary_10_1016_S0042_6989_99_00038_3 crossref_primary_10_1080_02713683_2016_1242754 crossref_primary_10_1111_j_1442_9071_2006_01146_x crossref_primary_10_1016_j_brainres_2005_07_005 crossref_primary_10_3736_jintegrmed2013037 crossref_primary_10_1002_jnr_24899 crossref_primary_10_1016_S0006_8993_01_02759_7 crossref_primary_10_1016_j_jneumeth_2008_05_018 crossref_primary_10_3892_mmr_2015_3882 crossref_primary_10_3390_ijms22157994 crossref_primary_10_1016_S0361_9230_03_00076_5 crossref_primary_10_1007_s11062_012_9240_x crossref_primary_10_1089_jop_1999_15_271 crossref_primary_10_1371_journal_pone_0130467 crossref_primary_10_1006_exer_1998_0641 crossref_primary_10_1073_pnas_041609498 crossref_primary_10_1016_j_exer_2011_07_014 crossref_primary_10_1080_02713680500536647 crossref_primary_10_1016_j_exer_2006_10_018 crossref_primary_10_1016_S0039_6257_99_00017_X crossref_primary_10_1046_j_1471_4159_2002_01229_x crossref_primary_10_1016_S1350_9462_98_00014_7 crossref_primary_10_1097_00055735_199904000_00002 crossref_primary_10_3109_08820539909061468 crossref_primary_10_1016_S0039_6257_99_00054_5 crossref_primary_10_1097_00055735_199904000_00004 crossref_primary_10_1016_j_mcn_2018_05_001 crossref_primary_10_1155_2007_36150 crossref_primary_10_3390_ijms21072262 crossref_primary_10_2217_ahe_11_51 crossref_primary_10_1111_j_1755_3768_2008_01459_x crossref_primary_10_1016_S0042_6989_01_00194_8 crossref_primary_10_1016_S1350_9462_02_00002_2 crossref_primary_10_1111_j_1600_0420_2007_01052_x crossref_primary_10_1159_000456704 crossref_primary_10_1016_S0006_8993_02_03372_3 crossref_primary_10_1080_02713683_2022_2142943 crossref_primary_10_3390_nu13061949 crossref_primary_10_5372_1905_7415_0502_025 crossref_primary_10_1111_j_1444_0938_2000_tb04910_x crossref_primary_10_1248_bpb_b15_00226 crossref_primary_10_1016_j_exer_2014_10_007 crossref_primary_10_1111_j_1755_3768_2011_02125_x crossref_primary_10_1016_S0306_3623_97_00357_1 crossref_primary_10_1016_S0006_8993_00_02887_0 crossref_primary_10_1016_j_mcn_2004_05_002 crossref_primary_10_1517_14656566_5_5_1071 crossref_primary_10_2174_1874364101509010089 crossref_primary_10_1007_s11064_014_1289_z crossref_primary_10_1097_ICU_0b013e3280895aea crossref_primary_10_1254_fpj_152_58 crossref_primary_10_1097_IJG_0b013e318181284f crossref_primary_10_1155_2018_6128470 crossref_primary_10_1016_j_ajo_2006_01_073 crossref_primary_10_1016_S0161_6420_00_00654_0 crossref_primary_10_1620_tjem_197_125 crossref_primary_10_1139_Y08_040 crossref_primary_10_1007_s00417_005_0060_1 crossref_primary_10_1111_j_1442_9071_2011_02496_x crossref_primary_10_1523_JNEUROSCI_20_13_05037_2000 crossref_primary_10_1016_j_exer_2005_07_013 crossref_primary_10_1016_S0042_6989_02_00188_8 crossref_primary_10_1177_1073858403253460 crossref_primary_10_1155_2013_528940 crossref_primary_10_1016_S0039_6257_99_00029_6 crossref_primary_10_1111_ceo_12525 crossref_primary_10_1006_exnr_1998_6881 crossref_primary_10_3390_ijms18112418 crossref_primary_10_1007_s10633_005_7341_1 crossref_primary_10_1016_S0161_6420_99_00133_5 crossref_primary_10_1016_j_preteyeres_2013_02_003 crossref_primary_10_3390_pharmaceutics15051370 crossref_primary_10_1517_13543776_14_12_1743 crossref_primary_10_2131_jts_45_261 crossref_primary_10_1007_BF02332864 crossref_primary_10_1016_j_survophthal_2015_01_004 crossref_primary_10_1016_j_nbd_2011_04_019 crossref_primary_10_1186_1471_2202_9_74 crossref_primary_10_1038_s42003_023_04918_8 crossref_primary_10_3389_fnagi_2021_747050 crossref_primary_10_1016_j_exer_2012_11_011 crossref_primary_10_1186_s12974_016_0542_6 crossref_primary_10_1007_s10571_015_0198_2 crossref_primary_10_1016_j_exer_2010_08_009 crossref_primary_10_1007_s10384_005_0253_5 crossref_primary_10_3109_08820539709059809 crossref_primary_10_1016_j_preteyeres_2013_09_001 crossref_primary_10_3390_nu11020239 crossref_primary_10_1016_j_brainres_2008_03_021 crossref_primary_10_1016_S0304_3940_01_01830_4 crossref_primary_10_1016_j_exer_2007_01_007 crossref_primary_10_1097_IJG_0b013e31818c6ef6 crossref_primary_10_1007_s00109_005_0689_6 crossref_primary_10_1007_BF03033307 crossref_primary_10_1089_neu_1997_14_665 crossref_primary_10_1097_OPX_0b013e31817841e5 crossref_primary_10_1016_S0039_6257_99_00044_2 crossref_primary_10_1111_j_1471_4159_2010_06724_x crossref_primary_10_1007_s00441_004_1062_8 crossref_primary_10_1016_j_preteyeres_2023_101169 crossref_primary_10_1002_glia_10082 crossref_primary_10_1016_j_exer_2015_06_005 crossref_primary_10_1177_112067211002000118 crossref_primary_10_1097_IJG_0000000000001328 crossref_primary_10_1016_j_exer_2005_10_031 crossref_primary_10_1080_02713680490522443 crossref_primary_10_1248_bpb_b17_00856 crossref_primary_10_3390_pharmaceutics13010028 crossref_primary_10_1007_BF03033795 crossref_primary_10_1371_journal_pone_0175451 crossref_primary_10_1016_S0140_6736_04_16257_0 crossref_primary_10_2460_ajvr_67_2_302 crossref_primary_10_1002_prca_200700105 crossref_primary_10_1016_j_neuroscience_2007_07_056 crossref_primary_10_1016_S0165_5728_01_00358_7 crossref_primary_10_1089_jop_2006_0118 crossref_primary_10_1016_j_exer_2020_108268 crossref_primary_10_1016_j_brainresbull_2003_07_005 crossref_primary_10_3390_cells7060060 crossref_primary_10_1016_S0014_4835_02_00333_0 crossref_primary_10_1016_S0039_6257_99_00010_7 crossref_primary_10_1016_j_exer_2010_04_002 crossref_primary_10_1007_s11064_011_0472_8 crossref_primary_10_1016_j_heliyon_2016_e00096 crossref_primary_10_1002_elps_200405941 crossref_primary_10_1016_j_jphs_2017_02_012 crossref_primary_10_1111_jnc_13765 crossref_primary_10_1016_S0042_6989_97_00444_6 crossref_primary_10_1016_S1734_1140_13_71066_1 crossref_primary_10_1016_j_ejphar_2012_11_054 crossref_primary_10_1089_neu_2006_23_1072 crossref_primary_10_3390_ijms20123012 crossref_primary_10_1007_s11064_015_1607_0 crossref_primary_10_1016_j_exer_2022_108979 crossref_primary_10_3390_ijms21020549 crossref_primary_10_1007_s00062_018_0728_7 crossref_primary_10_1016_S0161_6420_02_01247_2 crossref_primary_10_1006_exer_1997_0447 crossref_primary_10_1016_S0006_8993_03_02696_9 crossref_primary_10_1016_j_brainresbull_2009_04_004 crossref_primary_10_1007_s00441_013_1556_3 crossref_primary_10_6114_jkood_2016_29_3_059 crossref_primary_10_1186_s40478_024_01732_z crossref_primary_10_1002_pmic_200800978 crossref_primary_10_3390_toxins8030070 crossref_primary_10_1016_j_ejphar_2013_08_041 crossref_primary_10_1111_vop_12046 crossref_primary_10_2217_pme_10_25 crossref_primary_10_1038_eye_2016_37 crossref_primary_10_1096_fj_04_3403com crossref_primary_10_1016_j_preteyeres_2019_100799 crossref_primary_10_1016_j_brainres_2011_06_005 crossref_primary_10_1007_s12035_019_01658_x crossref_primary_10_1016_j_ajo_2004_02_021 crossref_primary_10_1111_j_1471_4159_2004_02474_x crossref_primary_10_1080_02713683_2022_2033270 crossref_primary_10_1155_2015_258281 crossref_primary_10_1007_s12031_013_0017_5 crossref_primary_10_1016_j_exer_2005_01_008 crossref_primary_10_1016_S0361_9230_03_00070_4 crossref_primary_10_1080_02713683_2019_1684523 crossref_primary_10_1016_S0039_6257_97_00123_9 crossref_primary_10_1021_jm9608725 crossref_primary_10_1111_j_0953_816X_2003_03107_x crossref_primary_10_1016_j_exer_2005_08_004 crossref_primary_10_1155_2020_9539681 crossref_primary_10_1007_s00441_013_1584_z crossref_primary_10_1002_cne_10830 crossref_primary_10_1002_ptr_2138 crossref_primary_10_1523_JNEUROSCI_1291_12_2012 crossref_primary_10_2147_OPTH_S354958 crossref_primary_10_1517_14728222_3_4_543 crossref_primary_10_1111_j_1600_0420_1999_tb01133_x crossref_primary_10_4199_C00122ED1V01Y201412NGL003 crossref_primary_10_3389_fphar_2021_705405 crossref_primary_10_4103_1673_5374_391193 crossref_primary_10_1016_j_phrs_2012_03_002 crossref_primary_10_3390_ijms24032985 crossref_primary_10_3390_jcm9103172 crossref_primary_10_1073_pnas_96_17_9455 crossref_primary_10_1016_j_neuro_2005_06_002 crossref_primary_10_1039_c1ob05951c crossref_primary_10_1016_j_exer_2019_02_022 crossref_primary_10_1111_j_1471_4159_2005_03214_x crossref_primary_10_1080_02713680600762747 crossref_primary_10_2460_ajvr_2005_66_791 crossref_primary_10_1016_S0197_0186_01_00033_X crossref_primary_10_1016_S0165_0270_99_00138_7 crossref_primary_10_1248_bpb_b12_00644 crossref_primary_10_1016_j_exer_2009_02_005 crossref_primary_10_1111_j_1755_5949_2008_00050_x crossref_primary_10_3389_fncel_2018_00312 crossref_primary_10_1038_sj_eye_6701623 crossref_primary_10_1517_13543784_7_7_1063 crossref_primary_10_1006_exer_2002_2017 crossref_primary_10_1016_S0006_8993_03_02298_4 crossref_primary_10_1016_S0361_9230_03_00071_6 crossref_primary_10_1038_s41598_021_89137_z crossref_primary_10_1039_C5AY01465D crossref_primary_10_1155_2017_4320408 crossref_primary_10_1016_S1350_9462_00_00028_8 crossref_primary_10_3129_can_j_ophthalmol_i07_036 crossref_primary_10_1006_exer_1997_0360 crossref_primary_10_1038_eye_2000_132 crossref_primary_10_1038_eye_2000_131 crossref_primary_10_1089_jmf_2012_2241 crossref_primary_10_1177_026119290002800317 crossref_primary_10_1016_S0039_6257_99_00012_0 crossref_primary_10_1016_j_acra_2009_03_019 crossref_primary_10_1097_IJG_0b013e3181405d4f crossref_primary_10_1177_112067210301303S02 crossref_primary_10_1089_jop_2005_21_175 crossref_primary_10_1177_112067210301303S04 crossref_primary_10_1007_s10571_009_9407_1 crossref_primary_10_1111_j_1365_2990_2007_00862_x crossref_primary_10_1002_ar_25060 crossref_primary_10_1177_112067210301303S05 crossref_primary_10_1016_j_neures_2023_02_004 crossref_primary_10_1111_j_1463_5224_2007_00529_x crossref_primary_10_1038_sj_eye_6701971 crossref_primary_10_1002_glia_24307 crossref_primary_10_1016_j_neures_2005_11_010 crossref_primary_10_1007_s00347_015_0007_9 crossref_primary_10_1007_s00221_009_1896_0 crossref_primary_10_1016_j_exer_2016_05_019 crossref_primary_10_1097_00061198_200206000_00012 crossref_primary_10_1097_00061198_200206000_00010 crossref_primary_10_1177_112067210101102S09 crossref_primary_10_1016_j_preteyeres_2006_07_003 crossref_primary_10_1177_112067210101102S01 crossref_primary_10_3390_molecules15031168 crossref_primary_10_1016_j_mam_2023_101225 crossref_primary_10_1016_S0039_6257_03_00008_0 crossref_primary_10_1016_j_omtm_2019_12_009 crossref_primary_10_3341_jkos_2008_49_7_1146 crossref_primary_10_1007_s00347_004_1129_7 crossref_primary_10_3390_biology10080763 crossref_primary_10_1016_j_preteyeres_2004_08_003 crossref_primary_10_1007_s00417_012_2255_6 crossref_primary_10_1016_j_exer_2012_07_011 crossref_primary_10_1097_00006324_200102000_00008 crossref_primary_10_3389_fnana_2024_1335176 crossref_primary_10_1056_NEJM199804093381511 crossref_primary_10_1177_1120672103013009_1003 crossref_primary_10_1016_S0006_8993_01_02706_8 crossref_primary_10_1111_j_1442_9071_1997_tb01290_x crossref_primary_10_3389_fnins_2019_00931 crossref_primary_10_1002_jnr_20679 crossref_primary_10_1016_j_visres_2007_07_011 crossref_primary_10_1002__SICI_1098_2299_199901_46_1_34__AID_DDR6_3_0_CO_2_A crossref_primary_10_1177_026119299902700319 crossref_primary_10_1111_j_1755_5949_2010_00176_x crossref_primary_10_1155_2018_2749257 crossref_primary_10_1016_S0361_9230_03_00073_X crossref_primary_10_1097_00061198_200212000_00003 crossref_primary_10_1117_1_1559726 crossref_primary_10_1002_jcb_25827 crossref_primary_10_1016_j_nbd_2011_06_009 crossref_primary_10_2165_11539090_000000000_00000 crossref_primary_10_1016_S0042_6989_98_00003_0 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1001/archopht.1996.01100130295012 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
ExternalDocumentID | 8600890 |
Genre | Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S Journal Article |
GrantInformation_xml | – fundername: NEI NIH HHS grantid: R01 EY05477 – fundername: NEI NIH HHS grantid: R01 EY10009 |
GroupedDBID | --- -QF .55 .XZ 23N 2CT 2WC 354 39C 3O- 4.4 53G 5GY 6J9 AAWTL ABCQX ABJNI ABOCM ACGFS ADBBV AFFNX ALMA_UNASSIGNED_HOLDINGS AMJDE ARBJA BAWUL BCGUY BRYMA C1A C45 CGR CS3 CUY CVF EAM EBS ECM EIF EJD EMOBN EX3 F5P L7B MJL N4W N9A NPM OB3 OBH OGROG OHH OVD P2P RAJ SJN SV3 TEORI WH7 WOW X7M XHN YOC ZGI ZXP ZY1 |
ID | FETCH-LOGICAL-a365t-3027e215b3518405b4f617f48ee10bcfb2fca464ef7ed647a90864c03b85f6db2 |
ISSN | 0003-9950 |
IngestDate | Sat Sep 28 08:37:48 EDT 2024 |
IsPeerReviewed | false |
IsScholarly | false |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-a365t-3027e215b3518405b4f617f48ee10bcfb2fca464ef7ed647a90864c03b85f6db2 |
PMID | 8600890 |
ParticipantIDs | pubmed_primary_8600890 |
PublicationCentury | 1900 |
PublicationDate | 1996-03-01 |
PublicationDateYYYYMMDD | 1996-03-01 |
PublicationDate_xml | – month: 03 year: 1996 text: 1996-03-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Archives of ophthalmology (1960) |
PublicationTitleAlternate | Arch Ophthalmol |
PublicationYear | 1996 |
SSID | ssj0006109 |
Score | 1.5698756 |
Snippet | To explore the possibility that the excitatory amino acid glutamate might be associated with the disease process of glaucoma, which is characterized by the... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 299 |
SubjectTerms | Aged Amino Acids - analysis Animals Aqueous Humor - metabolism Cataract - metabolism Cataract Extraction Disease Models, Animal Female Glaucoma - complications Glaucoma - metabolism Glutamic Acid - metabolism Humans Macaca fascicularis Male Prospective Studies Rats Retrospective Studies Vitrectomy Vitreous Body - metabolism |
Title | Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma |
URI | https://www.ncbi.nlm.nih.gov/pubmed/8600890 |
Volume | 114 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFA5TUfYi3oZ38rA3qWw2TbtH0ckQFJkK4oskbeLE2Q5tJ_joL_ecJl2Ll6G-lNHQLO35kn4nPec7hDThjQy0wIuciKuWg-p3TkdqFw7oXodum4W4D3l2znvX7PTGu6nV3itRS1kq98O3b_NK_mNVOAd2xSzZP1h20imcgN9gXziCheH4Kxt3h2oskDLew78I4J5qb4hBQC9F9OL4IX1WGOQqEyMdnZfkM7LMMEqYwDa7DUh0BiMUVa5aFaVNRoN0IIZPRrEJxZ3AJ6nsIhwDImzmTFnH-TZ7Fo_Jq62MXYYWh4PM1mzpl1upF-Af55i6tBu0kc3N42Us1mR5BSt3jJLsZHk1SaIWR251sTSlkb4s4qZ4AM5zvDnMp-T7ubQdfmSF3k3cdcW-o6fcwAGQt8AUH53a-Elg27bMkBk_wDXyHPd77LscxeiLmot4YwukWehWTRtfnczbXj95KzlruVoii9bdoIcGO8ukpuIVsnBmAypWSb-AEJ1AiBoI0YeYAoRoASGKEKKJpgZCFCBELYQoQogWEFoj1yfdq6OeY8tsOMLlXurgl2sFzE-6Hrr7nmQaaK1mgVLtlgy1PNChYJwp7auIM190wA1mYcuVgaexHFmDzMZJrNYJZYFW3BWo4icYXC78SIVRJDvMl0AE2xukYZ7G3choqdzZx7T5U8MWqZdI2yZzGqau2gEemMrd3FQfyFVY6A |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Elevated+glutamate+levels+in+the+vitreous+body+of+humans+and+monkeys+with+glaucoma&rft.jtitle=Archives+of+ophthalmology+%281960%29&rft.au=Dreyer%2C+E+B&rft.au=Zurakowski%2C+D&rft.au=Schumer%2C+R+A&rft.au=Podos%2C+S+M&rft.date=1996-03-01&rft.issn=0003-9950&rft.volume=114&rft.issue=3&rft.spage=299&rft_id=info:doi/10.1001%2Farchopht.1996.01100130295012&rft_id=info%3Apmid%2F8600890&rft_id=info%3Apmid%2F8600890&rft.externalDocID=8600890 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-9950&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-9950&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-9950&client=summon |